News Daily News HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding Caitlin E. Cox November 01, 2013
News Industry News OrbusNeich’s COMBO™ Dual Therapy Stent Featured in TCT 2013 Satellite Symposium October 31, 2013
News Industry News Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013 October 22, 2013
News Daily News Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina Caitlin E. Cox October 11, 2013
News Daily News High-Risk Subgroups Derive Kidney Protection from Rosuvastatin Caitlin E. Cox October 11, 2013
News Conference News ESC 2013 Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women Yael L. Maxwell September 02, 2013
News Conference News ESC 2013 Length of DAPT, Reasons for Discontinuation Have Disparate Effects Yael L. Maxwell September 01, 2013
News Daily News HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients Leah Lawrence July 11, 2013
News Industry News OrbusNeich Launches World’s First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents May 27, 2013
News Industry News STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial May 20, 2013
News Daily News REMEDEE Published: ‘Dual Therapy’ Stent Passes Early Efficacy, Safety Tests April 05, 2013
News Daily News REMEDEE Publicado: El Stente de ‘Tratamiento Doble’ Aprueba, sin Problemas, los Tests de Seguridad y Eficacia April 05, 2013
News Conference News ACC 2013 Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients L.A. McKeown March 09, 2013
News Conference News ACC 2013 Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients Yael L. Maxwell March 09, 2013
News Daily News Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno L.A. McKeown December 19, 2012
News Daily News High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit L.A. McKeown December 19, 2012